GILD Operating Cash Flow (Statement)

Gilead Sciences · Operating Cash Flow (Statement)

GILD logo

GILD Operating Cash Flow (Statement)

Latest reported$3.57B
GILD Quarterly Cash from Operations (-$2.10M → $3.57B)
High-resolution chart · PNG

GILD operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Gilead Sciences Operating Cash Flow (Statement) — Quarterly (USD)
Period endingOperating Cash Flow (Statement) (USD)
3,573,000,000
2,544,000,000
3,327,000,000
4,108,000,000
827,000,000
1,757,000,000
2,975,000,000
4,309,000,000
1,325,000,000
2,219,000,000
2,169,000,000
1,755,000,000
2,338,000,000
1,744,000,000
2,567,000,000
2,863,000,000
1,802,000,000
1,840,000,000
3,205,000,000
3,253,000,000
2,316,000,000
2,610,000,000
1,916,000,000
2,250,000,000
2,566,000,000
1,436,000,000
2,580,000,000
2,645,000,000
2,342,000,000
1,577,000,000
2,345,000,000
2,212,000,000
1,573,000,000
2,270,000,000
2,753,000,000
2,694,000,000
3,526,000,000
2,925,000,000
3,486,000,000
4,393,000,000
4,985,000,000
4,130,000,000
4,874,000,000
4,096,000,000
5,658,000,000
5,701,000,000
3,020,667,000
4,044,000,000
4,185,000,000
1,568,000,000
726,787,000
753,096,000
953,004,000
672,101,000
705,728,000
745,368,000
1,290,651,000
452,969,000
978,107,000
897,106,000
943,255,000
820,542,000
724,843,000
739,422,000
699,079,000
670,569,000
955,276,000
860,531,000
622,917,000
641,330,000
646,030,000
512,048,000
441,070,000
605,511,000
511,986,000
251,198,000
511,721,000
490,493,000
479,508,000
250,758,000
265,899,000
221,894,000
340,449,000
-141,401,000
288,807,000
227,225,000
124,048,000
166,636,000
122,488,000
98,206,000
99,913,000
54,310,000
59,442,000
20,942,000
35,548,000
60,766,000
1,210,000
-23,115,000
4,630,000
-31,099,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.